Titre:
  • Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma.
Auteur:Eggermont, A; Suciu, Stefan; Testori, Alessandro; Santinami, M.; Kruit, Wim H; Marsden, Jeremy; Punt, Cornelis; Sales, François; Dummer, Reinhard; Robert, Caroline; Schadendorf, Dirk; Patel, Poulam; de Schaetzen, Gaetan; Spatz, Alain; Keilholz, Ulrich
Informations sur la publication:Journal of clinical oncology, 30, 31, page (3810-3818)
Statut de publication:Publié, 2012-11
Sujet CREF:Cancérologie
MeSH keywords:Adolescent
Adult
Aged
Chemotherapy, Adjuvant
Follow-Up Studies
Humans
Interferon-alpha -- therapeutic use
Melanoma -- drug therapy -- pathology -- surgery
Middle Aged
Neoplasm Staging
Polyethylene Glycols -- therapeutic use
Recombinant Proteins -- therapeutic use
Skin Neoplasms -- drug therapy -- pathology -- surgery
Young Adult
Note générale:Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2011.41.3799
info:pii/JCO.2011.41.3799
info:scp/84869212118
info:pmid/23008300